Saliva Diagnostic Systems, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Saliva Diagnostic Systems, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Saliva Diagnostic Systems, Inc.. The Company's principal activity is the development, manufacture and marketing of rapid immunoassays for use in the detection of infectious diseases and medical specimen collection devices. The Company's products fall into two categories: Rapid Immunoassays and Medical specimen collection devices. The Company has developed four rapid tests utilizing immunochromatography for the detection of antibodies to selected pathogens, including HIV and Helicobacter pylori. Rapid immunoassays products include Sero-Strip HIV, Hema-Strip HIV and Saliva-Strip HIV. Medical specimen collection device includes Omni SAL(R). This product is a patented saliva collection device currently sold to several commercial companies for use with their laboratory assays for the detection of HIV infection, drugs-of-abuse and cigarette smoking. The Company markets its products in the United States, the United Kingdom, Canada, Caribbean, Asia and Africa.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report